ADVANCED ENZYME TECHNOLOGIES
Back to Income Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹746 Cr | ₹637 Cr | ₹624 Cr | ₹541 Cr | ₹529 Cr |
What is the latest Revenue of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹746 Cr |
| Mar2025 | ₹637 Cr |
| Mar2024 | ₹624 Cr |
| Mar2023 | ₹541 Cr |
| Mar2022 | ₹529 Cr |
How is Revenue of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹746 Cr | 17.09 | |
| Mar2025 | ₹637 Cr | 2.09 | |
| Mar2024 | ₹624 Cr | 15.39 | |
| Mar2023 | ₹541 Cr | 2.13 | |
| Mar2022 | ₹529 Cr | - | |
Compare Revenue of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,327.0 Cr | 3.1% | -1.7% | -12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,476.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,764.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,423.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,005.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 3.1% |
-1.7% |
-12.7% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses